- Expression of the EGF-TM7 receptor CD97 and its ligand CD55 (DAF) in multiple sclerosis. Visser, L., de Vos, A.F., Hamann, J., Melief, M.J., van Meurs, M., van Lier, R.A., Laman, J.D., Hintzen, R.Q. J. Neuroimmunol. (2002)
- CD97, an adhesion receptor on inflammatory cells, stimulates angiogenesis through binding integrin counterreceptors on endothelial cells. Wang, T., Ward, Y., Tian, L., Lake, R., Guedez, L., Stetler-Stevenson, W.G., Kelly, K. Blood (2005)
- Expression and regulation of CD97 in colorectal carcinoma cell lines and tumor tissues. Steinert, M., Wobus, M., Boltze, C., Schütz, A., Wahlbuhl, M., Hamann, J., Aust, G. Am. J. Pathol. (2002)
- Expression of the epidermal growth factor seven-transmembrane member CD97 correlates with grading and staging in human oral squamous cell carcinomas. Mustafa, T., Eckert, A., Klonisch, T., Kehlen, A., Maurer, P., Klintschar, M., Erhuma, M., Zschoyan, R., Gimm, O., Dralle, H., Schubert, J., Hoang-Vu, C. Cancer Epidemiol. Biomarkers Prev. (2005)
- The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF). Hamann, J., Vogel, B., van Schijndel, G.M., van Lier, R.A. J. Exp. Med. (1996)
- Regulation of CD97 protein in thyroid carcinoma. Hoang-Vu, C., Bull, K., Schwarz, I., Krause, G., Schmutzler, C., Aust, G., Köhrle, J., Dralle, H. J. Clin. Endocrinol. Metab. (1999)
- Characterization of the CD55 (DAF)-binding site on the seven-span transmembrane receptor CD97. Hamann, J., Stortelers, C., Kiss-Toth, E., Vogel, B., Eichler, W., van Lier, R.A. Eur. J. Immunol. (1998)
- Human EMR2, a novel EGF-TM7 molecule on chromosome 19p13.1, is closely related to CD97. Lin, H.H., Stacey, M., Hamann, J., Gordon, S., McKnight, A.J. Genomics (2000)
- Structural characterization of mouse CD97 and study of its specific interaction with the murine decay-accelerating factor (DAF, CD55). Qian, Y.M., Haino, M., Kelly, K., Song, W.C. Immunology (1999)
- An unusual mode of concerted evolution of the EGF-TM7 receptor chimera EMR2. Kwakkenbos, M.J., Matmati, M., Madsen, O., Pouwels, W., Wang, Y., Bontrop, R.E., Heidt, P.J., Hoek, R.M., Hamann, J. FASEB J. (2006)
- CD97: a dedifferentiation marker in human thyroid carcinomas. Aust, G., Eichler, W., Laue, S., Lehmann, I., Heldin, N.E., Lotz, O., Scherbaum, W.A., Dralle, H., Hoang-Vu, C. Cancer Res. (1997)
- The human EGF-TM7 family member EMR2 is a heterodimeric receptor expressed on myeloid cells. Kwakkenbos, M.J., Chang, G.W., Lin, H.H., Pouwels, W., de Jong, E.C., van Lier, R.A., Gordon, S., Hamann, J. J. Leukoc. Biol. (2002)
- CD97 isoform expression in leukocytes. Eichler, W. J. Leukoc. Biol. (2000)
- Expression of the largest CD97 and EMR2 isoforms on leukocytes facilitates a specific interaction with chondroitin sulfate on B cells. Kwakkenbos, M.J., Pouwels, W., Matmati, M., Stacey, M., Lin, H.H., Gordon, S., van Lier, R.A., Hamann, J. J. Leukoc. Biol. (2005)
- Expression cloning and chromosomal mapping of the leukocyte activation antigen CD97, a new seven-span transmembrane molecule of the secretion receptor superfamily with an unusual extracellular domain. Hamann, J., Eichler, W., Hamann, D., Kerstens, H.M., Poddighe, P.J., Hoovers, J.M., Hartmann, E., Strauss, M., van Lier, R.A. J. Immunol. (1995)
- The human EGF-TM7 receptor EMR3 is a marker for mature granulocytes. Matmati, M., Pouwels, W., van Bruggen, R., Jansen, M., Hoek, R.M., Verhoeven, A.J., Hamann, J. J. Leukoc. Biol. (2007)
- Molecular cloning and characterization of mouse CD97. Hamann, J., van Zeventer, C., Bijl, A., Molenaar, C., Tesselaar, K., van Lier, R.A. Int. Immunol. (2000)